Evidence map›Paper›PMID 25880592›Full record

ArticleJournal of human hypertension2016

Potential effects of age on screening for primary aldosteronism.

Q Luo, N F Li, X G Yao, D L Zhang, S F Y Abulikemu, G J Chang, K M Zhou, G L Wang, M H Wang, W J Ouyang and 2 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Journal of human hypertension, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Effect of Age on Aldosterone-Renin Ratio in Screening Primary Aldosteronism.Journal of clinical hypertension (Greenwich, Conn.) · 2025
    Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Long-term impact of spironolactone compliance on microalbuminuria in patients with primary aldosteronism.Hypertension research : official journal of the Japanese Society of Hypertension · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Association Between Polymorphisms of ADRBK1 Gene and Plasma Renin Activity in Hypertensive Patients: A Case-Control Study.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Q LuoHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital Of Xinjiang Uygur Autonomous Region, Urumqi, China.
N F LiHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital Of Xinjiang Uygur Autonomous Region, Urumqi, China.
X G YaoHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital Of Xinjiang Uygur Autonomous Region, Urumqi, China.
D L ZhangHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital Of Xinjiang Uygur Autonomous Region, Urumqi, China.
S F Y AbulikemuHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital Of Xinjiang Uygur Autonomous Region, Urumqi, China.
G J ChangHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital Of Xinjiang Uygur Autonomous Region, Urumqi, China.
K M ZhouHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital Of Xinjiang Uygur Autonomous Region, Urumqi, China.
G L WangHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital Of Xinjiang Uygur Autonomous Region, Urumqi, China.
M H WangHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital Of Xinjiang Uygur Autonomous Region, Urumqi, China.
W J OuyangHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital Of Xinjiang Uygur Autonomous Region, Urumqi, China.
Q Y ChengHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital Of Xinjiang Uygur Autonomous Region, Urumqi, China.
Y JiaHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital Of Xinjiang Uygur Autonomous Region, Urumqi, China.
People's Hospital of Xinjiang Uygur Autonomous Region · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aldosterone/renin ratio (ARR) is currently regarded as the most reliable and available screening test for primary aldosteronism (PA), however, the falling accuracy of ARR with increasing age has posed crucial challenge for PA screening among older-aged population. To clarify potential effects of age on screening for PA, 216 subjects with PA and 657 subjects with non-PA were recruited and subdivided into four age groups (⩽39, 40-49, 50-59 and ⩾60 years) and their biochemical parameters were compared. As expected, plasma renin activity (PRA) lowered more than plasma aldosterone concentration (PAC) and led to gradually elevated ARR with increasing age in the non-PA group (P<0.001), whereas this phenomenon was unconspicuous in the PA group. The best cut-off values of ARR for PA screening were elevated in subjects ⩾50 years, whereas the area under the receiver operating characteristic curves (AUCs), sensitivity, specificity and Youden's index (YI) of ARR were declined with increasing age, especially in patients ⩾60 years (AUC=0.863, sensitivity=95.2%, specificity=69.0%, YI=0.643). The AUCs of PAC increased with increasing age and even slightly surpassed that of ARR in patients ⩾60 years (AUCPAC=0.884). Our data suggest that the criteria of ARR for PA screening in patients ⩾50 years may need setting higher; the falling accuracy of ARR with increasing age, especially in patients ⩾60 years, could be improved by taking into account the absolute value of the PAC when applicable by the center.

Indexed as

AdultAgedAge FactorsAldosteroneBiomarkersFemaleHumansHyperaldosteronismMaleMiddle AgedReninSensitivity and SpecificityAldosteroneBiomarkersRenin

Identifiers

PMID25880592
OpenAlexW2060205298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.